Investigator Site Profiler

Greater precision, greater enrollment

Eliminate 20-30% of sites from investigator site lists and accelerate enrollment

Introducing Investigator Site Profiler

Investigator site selection is pivotal to clinical trial success. Poor decisions lead to trial delays and failures. Selecting the right investigator sites provides a strategic advantage for sponsors. Our self-service Investigator Site Profiler delivers greater precision in investigator site selection, improving enrollment. It enables objective decisions to be derived from the largest source of global real-world data, leveraging Phesi’s AI-powered Trial Accelerator platform which has been proven to support the commercialization of many high profile, innovative life saving therapies.